GlassScriptPhysician profile
Jonathan N Tam
NPI 1013942952
$5,015.07
in general payments reported to CMS, 2019-2025
17 companies · $32.34 in 2025
The $32.34 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,425 · 2020: $715 · 2021: $1,484 · 2022: $715 · 2023: $316 · 2024: $328 · 2025: $32.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $676.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $675.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,914.81 | 2019-2024 | Lo Loestrin Fe, Orilissa |
| Myovant Sciences INC. | $216.99 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $149.54 | 2019 | |
| Novartis Pharmaceuticals Corporation | $145.34 | 2024 | |
| Acacia Pharma INC | $126.53 | 2021 | |
| Avion Pharmaceuticals | $64.49 | 2021-2022 | |
| Roche Diagnostics Corporation | $51.72 | 2019 | |
| Allergan, INC. | $50.17 | 2019 | |
| Sumitomo Pharma America, INC. | $50.06 | 2023-2024 | Myfembree |
| Coloplast Corp | $42.93 | 2019-2021 | |
| Therapeuticsmd, INC. | $40.19 | 2020-2021 | |
| Exeltis, USA INC. | $36.33 | 2024 | Slynd |
| Merz North America, INC. | $36.20 | 2023 | Xeomin |
| Sage Therapeutics, LLC | $32.34 | 2025 | Zurzuvae |
| Organon LLC | $22.03 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $19.28 | 2021 | |
| Alydia Health | $16.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Tam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.